Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs

Annual Review of Immunology

Volumn 23, Issue , 2005, Pages 127-159

  Cyster, Jason G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CCR7; CXCR4; CXCR5; Exit; S1P

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CXCL13 ANTIGEN; FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; IMMUNOSUPPRESSIVE AGENT; LYMPHOTOXIN ALPHA1BETA2; SECONDARY LYMPHOID TISSUE CHEMOKINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; SPHINGOSINE KINASE; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL MIGRATION; CELL MOTION; CELLULAR IMMUNITY; CHEMOTAXIS; DENDRITIC CELL; DOWN REGULATION; GERMINAL CENTER; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPH FOLLICLE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE TRANSFER; LYMPHOID CELL; LYMPHOID ORGAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SECONDARY LYMPHOID ORGAN; STROMA CELL; SYSTEMATIC REVIEW; THYMUS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIGEN-PRESENTING CELLS; CELL MOVEMENT; CHEMOKINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; LYMPHOID TISSUE; LYSOPHOSPHOLIPIDS; MODELS, IMMUNOLOGICAL; PLASMA CELLS; PROPYLENE GLYCOLS; RECEPTORS, CHEMOKINE; SPHINGOSINE;

EID: 17644365138     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.23.021704.115628     Document Type: Review

References (197)

1. McMaster PD, Hudack SS. 1935. The formation of agglutinins within lymph nodes. J. Exp. Med. 61:783-805
2. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. 2000. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6:686-88
3. Rennert PD, Hochman PS, Flavell RA, Chaplin DD, Jayaraman S, et al. 2001. Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-α-deficient mice. J. Exp. Med. 193:1227-38
4. Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-27
5. Rot A, von Andrian UH. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22:891-928
6. Thelen M. 2001. Dancing to the tune of chemokines. Nat. Immunol. 2:129-34
7. Tian Y, New DC, Yung LY, Allen RA, Slocombe PM, et al. 2004. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Gα14-coupled pathways. Eur. J. Immunol. 34:785-95
8. Cyster JG. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286:2098-102
9. Muller G, Hopken UE, Lipp M. 2003. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 195:117-35
10. von Andrian UH, Mempel TR. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867-78
11. Miyasaka M, Tanaka T. 2004. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 4:360-70
12. Rosen SD. 2004. Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 22:129-56
13. Brelinska R, Pilgrim C. 1982. The significance of the subcompartments of the marginal zone for directing lymphocyte traffic within the splenic pulp of the rat. Cell Tissue Res. 226:155-65
14. van Ewijk W, Nieuwenhuis P. 1985. Compartments, domains and migration pathways of lymphoid cells in the splenic pulp. Experientia 41:199-208
15. Nieuwenhuis P, Ford WL. 1976. Comparative migration of B- and T-lymphocytes in the rat spleen and lymph nodes. Cell Immunol. 23:254-67
16. Lo CG, Lu TT, Cyster JG. 2003. Integrin-dependence of lymphocyte entry into the splenic white pulp. J. Exp. Med. 197:353-61
17. Nolte MA, Hamann A, Kraal G, Mebius RE. 2002. The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors. Immunology 106:299-307
18. Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-47
19. Förster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33
20. Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87:1037-47
21. Ansel KM, Ngo VN, Hyman PL, Luther SA, Förster R, et al. 2000. A chemokine driven positive feedback loop organizes lymphoid follicles. Nature 406:309-14
22. Ansel KM, Harris RB, Cyster JG. 2002. CXCL13 is required for b1 cell homing, natural antibody production, and body cavity immunity. Immunity 16:67-76
23. Cyster JG, Ngo VN, Ekland EH, Gunn MD, Sedgwick JD, Ansel KM. 1999. Chemokines and B-cell homing to follicles. Curr. Top. Microbiol Immunol. 246:87-92
24. Bowman EP, Campbell JJ, Soler D, Dong Z, Manlongat N, et al. 2000. Developmental switches in chemokine response profiles during B cell differentiation and maturation. J. Exp. Med. 191:1303-18
25. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391:799-803
26. Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, et al. 1999. Lymphotoxin α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:403-12
27. Cyster JG, Ansel KM, Reif K, Ekland EH, Hyman PL, et al. 2000. Follicular stromal cells and lymphocyte homing to follicles. Immunol. Rev. 176:181-93
28. + dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193:1393-402
29. Vissers JL, Hartgers FC, Lindhout E, Figdor CG, Adema GJ. 2001. BLC (CXCL13) is expressed by different dendritic cell subsets in vitro and in vivo. Eur. J. Immunol. 31:1544-49
30. Ito T, Ishikawa S, Sato T, Akadegawa K, Yurino H, et al. 2004. Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus. J. Immunol. 172:3628-34
31. Miller MJ, Wei SH, Parker I, Cahalan MD. 2002. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296:1869-73
32. Ming GL, Wong ST, Henley J, Yuan XB, Song HJ, et al. 2002. Adaptation in the chemotactic guidance of nerve growth cones. Nature 417:411-18
33. Kraal G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31-73
34. Martin F, Kearney JF. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2:323-35
35. Lu TT, Cyster JG. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297:409-12
36. MacLennan ICM, Gray D, Kumararatne DS, Bazin H. 1982. The lymphocytes of splenic marginal zones: a distinct B-cell lineage, Immunol. Today 3:305-7
37. Cinamon C, Matloubian M, Lesneski MJ, Xu Y, Low C, et al. 2004. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5:713-20
38. Karlsson MC, Guinamard R, Bolland S, Sankala M, Steinman RM, Ravetch JV. 2003. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198:333-40
39. Yu P, Wang Y, Chin RK, Martinez-Pomares L, Gordon S, et al. 2002. B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J. Immunol. 168:5117-23
40. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, et al. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451-60
41. Bousso P. Robey E. 2003. Dynamics of CDS+ T cell priming by dendritic cells in intact lymph nodes. Nat Immunol. 5:579-85
42. Miller MJ, Wei SH, Cahalan MD, Parker I. 2003. Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proc. Natl. Acad. Sci. USA 100:2604-9
43. Mempel TR, Henrickson SE, Von Andrian UH. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427:154-59
44. Miller MJ, Hejazi AS, Wei SH, Cahalan MD, Parker I. 2004. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc. Natl. Acad. Sci. USA 101:998-1003
45. Gretz JE, Anderson AO, Shaw S. 1997. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol. Rev. 156:11-24
46. Luther SA, Tang HL, Hyman PL, Farr AG, Cyster JG. 2000. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. USA 97:12694-99
47. Nolle MA, Belien JA, Schadee-Eestermans I, Jansen W, Unger WW, et al. 2003. A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp. J. Exp. Med. 198:505-12
48. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, et al. 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169:424-33
49. Stein JV, Rot A, Luo Y, Narasimhaswamy M, Nakano H, et al. 2000. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191:61-76
50. Chen SC, Vassileva G, Kinsley D, Holzmann S, Manfra D, et al. 2002. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168:1001-8
51. Kuprash DV, Alimzhanov MB, Tumanov AV, Grivennikov SI, Shakhov AN, et al. 2002. Redundancy in tumor necrosis factor (TNF) and lymphotoxin (LT) signaling in vivo: mice with inactivation of the entire TNF/LT locus versus single-knockout mice. Mol. Cell. Biol. 22:8626-34
52. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, et al. 2002. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17:525-35
53. Lo JC, Chin RK, Lee Y, Kang HS, Wang Y, et al. 2003. Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J. Clin. Invest. 112:1495-505
54. Fu Y-X, Chaplin DD. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17:399-433
55. Ngo VN, Cornall RJ, Cyster JG. 2001. Splenic T zone development is B cell dependent. J. Exp. Med. 194:1649-60
56. Fagarasan S, Shinkura R, Kamata T, Nogaki F, Ikuta K, et al. 2000. Alymphoplasia (aly)-type nuclear factor/κB-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system. J. Exp. Med. 191:1477-86
57. Weih F, Caamano J. 2003. Regulation of secondary lymphoid organ development by the nuclear factor-κB signal transduction pathway. Immunol. Rev. 195:91-105
58. Gommerman JL, Browning JL. 2003. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3:642-55
59. Tumanov A, Kuprash D, Lagarkova M, Grivennikov S, Abe K, et al. 2002. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity 17:239-50
60. Ansel KM, Cyster JG. 2001. Chemokines in lymphopoiesis and lymphoid organ development. Curr. Opin. Immunol. 13:172-79
61. Mebius RE. 2003. Organogenesis of lymphoid tissues. Nat, Rev. Immunol. 3:292-303
62. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7:493-504
63. Honda K, Nakano H, Yoshida H, Nishikawa S, Rennert P, et al. 2001. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J. Exp. Med. 193:621-30
64. Luther SA, Ansel KM, Cyster JG. 2003. Overlapping Roles of CXCL13, interleukin 7 receptor α, and CCR7 ligands in lymph node development. J. Exp. Med. 197:1191-98
65. Eberl G, Littman DR. 2003. The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195:81-90
66. Nishikawa S, Honda K, Vieira P, Yoshida H. 2003. Organogenesis of peripheral lymphoid organs. Immunol. Rev. 195:72-80
67. Nossal GJ, Abbot A, Mitchell J, Lummus Z. 1968. Antigens in immunity. XV. U1-trastructural features of antigen capture in primary and secondary lymphoid follicles. J. Exp. Med. 127:277-90
68. Itano AA, Jenkins MK. 2003. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 4:733-39
69. Humphrey JH, Grennan D. 1981. Different macrophage populations distinguished by means of fluorescent polysaccharides. Recognition and properties of marginal-zone macrophages. Eur. J. Immunol. 11:221-28
70. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S. 2000. Lymphborne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192:1425-40
71. Kellermann SA, Hudak S, Oldham ER, Liu YJ, McEvoy LM. 1999. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3β are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J. Immunol. 162:3859-64
72. + dendritic cells. Nat. Immunol. 1:83-87
73. Iwasaki A, Kelsall BL. 2000. Localization of distinct Peyer's patch dendritic cell sub-sets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine. J. Exp. Med. 191:1381-94
74. Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, et al. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12:495-503
75. Varona R, Villares R, Carramolino L, Goya I, Zaballos A, et al. 2001. CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses. J. Clin. Invest 107:R37-45
76. + dendritic cells. J. Immunol. 171:2797-803
77. Szakal AK, Holmes KL, Tew JG. 1983. Transport of immune complexes from the subcapsular sinus to lymph node follicles on the surface of nonphagocytic cells, including cells with dendritic morphology. J. Immunol. 131:1714-27
78. Groeneveld PH, Erich T, Kraal G. 1986. The differential effects of bacterial lipopolysaccharide (LPS) on splenic nonlymphoid cells demonstrated by monoclonal antibodies. Immunology 58:285-90
79. Martinez-Pomares L, Kosco-Vilbois M, Darley E, Tree P, Herren S, et al. 1996. Fc chimeric protein containing the cysteinerich domain of the murine mannose receptor binds to macrophages from splenic marginal zone and lymph node subcapsular sinus and to germinal centers. J. Exp. Med. 184:1927-37
80. Berney C, Herren S, Power CA, Gordon S, Martinez-Pomares L, Kosco-Vilbois MH. 1999. A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein. J. Exp. Med. 190:851-60
81. Gray D, Kumararatne DS, Lortan J, Khan M, MacLennan IC. 1984. Relation of intra-splenic migration of marginal zone B cells to antigen localization on follicular dendritic cells. Immunology 52:659-69
82. Oldfield S, Lortan JE, Hyatt MA, MacLennan IC. 1988. Marginal zone B cells and the localisation of antigen on follicular dendritic cells. Adv. Exp. Med. Biol. 237:99-104
83. Cyster JG. 1999. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med. 189:447-50
84. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12:471-81
85. Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, et al. 2000. CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192:205-18
86. Peters W, Dupuis M, Charo IF. 2000. A mechanism for the impaired IFN-γ production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses. J. Immunol. 165:7072-77
87. Penna G, Sozzani S, Adorini L. 2001. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 167:1862-66
88. Krug A, Uppaluri R, Facchetti F, Dorner BG, Sheehan KC, et al. 2002. IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J. Immunol. 169:6079-83
89. Shortman K, Liu YJ. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-61
90. Balazs M, Martin F, Zhou T, Kearney J. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17:341-52
91. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59-70
92. Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, et al. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416:94-99
93. Seo SJ, Fields ML, Buckler JL, Reed AJ, Mandik-Nayak L, et al. 2002. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16:535-46
94. Ekland EH, Forster R, Lipp M, Cyster JG. 2004. Requirements for follicular exclusion and competitive elimination of autoantigen binding B cells. J. Immunol. 172:4700-8
95. Mandik-Nayak L, Huang G, Sheehan KC, Erikson J, Chaplin DD. 2001. Signaling through TNF receptor p55 in TNF-α-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle. J. Immunol. 167:1920-28
96. Bowman EP, Campbell JJ, Druey KM, Scheschonka A, Kehrl JH, Butcher EC. 1998. Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members. J. Biol. Chem. 273:28040-48
97. Reif K, Cyster JG. 2000. RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J. Immunol. 164:4720-29
98. Shi GX, Harrison K, Wilson GL, Moratz C, Kehrl JH. 2002. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J. Immunol. 169:2507-15
99. Kavelaars A, Vroon A, Raatgever RP, Fong AM, Premont RT, et al. 2003. Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6. J. Immunol. 171:6128-34
100. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD. 2002. Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. USA 99:7478-83
101. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, et al. 1999. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29:1617-25
102. Tang HL, Cyster JG. 1999. Chemokine upregulation and activated T cell attraction by maturing dendritic cells. Science 284:819-22
103. Alferink J, Lieberam I, Reindl W, Behrens A, Weiss S, et al. 2003. Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J. Exp. Med. 197:585-99
104. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. 2001. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 194:1541-47
105. Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, et al. 2003. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424:88-93
106. Stagg AJ, Hart AL, Knight SC, Kamm MA. 2003. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 52:1522-29
107. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG. 1999. In vivo activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J. Exp. Med. 190:1123-34
108. Randolph DA, Huang G, Carruthers CJ, Bromley LE, Chaplin DD. 1999. The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo. Science 286:2159-62
109. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192:1553-62
110. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, et al. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192:1545-52
111. + T cells. J. Exp. Med. 193:1373-81
112. Campbell DJ, Kim CH, Butcher EC. 2001. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat. Immunol. 2:876-81
113. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. 2001. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2:1126-32
114. + T cells. Curr. Opin. Immunol. 15:690-96
115. Mori S, Nakano H, Aritomi K, Wang CR, Gunn MD, Kakiuchi T. 2001. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 193:207-18
116. + regulatory T cells. J. Exp. Med. 194:847-53
117. + human thymocytes. J. Exp. Med. 196:379-87
118. Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, et al. 2001. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194:45-56
119. Wehrli N, Legier DF, Finke D, Toellner K-M, Loetscher P, et al. 2001. Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur. J. Immunol. 31:609-16
120. Hauser AE, Debes GF, Arce S, Cassese G, Hamann A, et al. 2002. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J. Immunol. 169:1277-82
121. Cyster JG. 2003. Homing of antibody secreting cells. Immunol. Rev. 194:48-60
122. Kunkel EJ, Butcher EC. 2003. Plasmacell homing. Nat. Rev. Immunol. 3:822-29
123. Voigt I, Camacho SA, de Boer BA, Lipp M, Förster R, Berek C. 2000. CXCR5-deficient mice develop functional germinal centers in the splenic T cell zone. Eur. J. Immunol. 30:560-67
124. MacLennan ICM. 1994. Germinal centers. Annu. Rev. Immunol. 12:117-39
125. Allen CDC, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, Cyster JG. 2004. Germinal center dark and light zone organization is mediated by CXCR4. Nat. Immunol. In press
126. Pelletier AJ, van der Laan LJ, Hildbrand P, Siani MA, Thompson DA, et al. 2000. Presentation of chemokine SDF-1α by fibronectin mediates directed migration of T cells. Blood 96:2682-90
127. Nagakubo D, Murai T, Tanaka T, Usui T, Matsumoto M, et al. 2003. A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. J. Immunol. 171:553-61
128. Moser B, Wolf M, Walz A, Loetscher P. 2004. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 25:75-84
129. Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, et al. 2002. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111:343-56
130. Freeman M, Gurdon JB. 2002. Regulatory principles of developmental signaling. Annu. Rev. Cell Dev. Biol. 18:515-39
131. Gowans JL, Knight EJ. 1964. The route of re-circulation of lymphocytes in the rat. Proc. R. Soc. London Ser. B 159:257-82
132. Ford WL. 1968. The mechanism of lymphopenia produced by chronic irradiation of the rat spleen. Br. J. Exp. Pathol. 49:502-10
133. Ford WL. 1969. The immunological and migratory properties of the lymphocytes recirculating through the rat spleen. Br. J. Exp. Pathol. 50:257-69
134. Soderstrom N, Stenstrom A. 1969. Outflow paths of cells from the lymph node parenchyma to the efferent lymphatics-observations in thin section histology. Scand. J. Haematol. 6:186-96
135. Kelly RH. 1975. Functional anatomy of lymph nodes. I. The paracortical cords. Int. Arch. Allergy Appl. Immunol. 48:836-49
136. Belisle C, Sainte-Marie G. 1981. Tridimensional study of the deep cortex of the rat lymph node. III. Morphology of the deep cortex units. Anal. Rec. 199:213-26
137. Tsuzuki Y, Miura S, Suematsu M, Kurose I, Shigematsu T, et al. 1996. alpha 4 integrin plays a critical role in early stages of T lymphocyte migration in Peyer's patches of rats. Int. Immunol. 8:287-95
138. Azzali G. 2003. Structure, lymphatic vascularization and lymphocyte migration in mucosa-associated lymphoid tissue, Immunol. Rev. 195:178-89
139. Bowdler AJ, ed. 1990. The Spleen. Structure, Function and Clinical Significance. London: Chapman & Hall Med. 515 pp.
140. Chaffin KE, Perlmutter RM. 1991. A pertussis toxin sensitive process controls thymocyte emigration. Eur. J. Immunol. 21:2565-73
141. Fujita T, Inoue K, Yamamoto S, Ikumoto T, Sasaki S, et al. 1994. Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J. Antibiot. 47:208-15
142. Miyake Y, Kozutsumi Y, Nakamura S, Fujita T, Kawasaki T. 1995. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem. Biophys. Res. Commun. 211:396-403
143. Fujita T, Hirose R, Yoneta M, Sasaki S, Inoue K, et al. 1996. Potent immunosuppressants, 2-alkyl-2-aminopropane-1,3-diols. J. Med. Chem. 39:4451-59
144. Brinkmann V, Cyster JG, Hla T. 2004. FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am. J. Transplant. 4:1019-25
145. Suzuki S, Enosawa S, Kakefuda T, Shinomiya T, Amari M, et al. 1996. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 61:200-5
146. Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, et al. 1998. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160:5037-44
147. Yagi H, Kamba R, Chiba K, Soga H, Yaguchi K, et al. 2000. Immunosuppressant FTY720 inhibits thymocyte emigration. Eur. J. Immunol. 30:1435-44
148. Budde K, Schmouder RL, Nashan B, Brunkhorst R, Lücker PW, et al. 2003. Pharmacodynamics of single doses of the novel immunosuppressant FTY720 instable renal transplant patients. Am. J. Transplant. 3:846-54
149. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, et al. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296:346-49
150. Henning G, Ohl L, Junt T, Reiterer P, Brinkmann V, et al. 2001. CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720. J. Exp. Med. 194:1875-81
151. + T-lymphocyte subpopulations expressing chemokine and adhesion receptors. Nephrol. Dial. Transplant. 19:702-13
152. Rosen H, Alfonso C, Surh CD, McHeyzer-Williams MG. 2003. Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist. Proc. Natl. Acad. Sci. USA 100:10907-12
153. + T cells. J. Immunol. 170:3662-70
154. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, et al. 2002. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277:21453-57
155. Paugh SW, Payne SG, Harbour SE, Milstien S, Spiegel S. 2003. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett. 554:189-93
156. Spiegel S, Milstien S. 2003. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4:397-407
157. Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, et al. 1998. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279:1552-55
158. Hla T. 2003. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol. Res. 47:401-7
159. Ishii I, Fukushima N, Ye X, Chun J. 2004. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73:321-54
160. Graler MH, Goetzl EJ. 2004. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors. FASEB J. 18:551-53
161. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, et al. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355-60
162. 1, on T-cells controls thymic emigration. J. Biol. Chem. 279:15396-401
163. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, et al. 2000. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106:951-61
164. Forrest M, Sun SY, Hajdu R, Bergstrom J, Card D, et al. 2004. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor sub-types. J. Pharmacol. Exp. Ther. 309:758-68
165. 3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 279:13839-48
166. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, et al. 2003. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem. 278:47281-90
167. Hale JJ, Neway W, Mills SG, Hajdu R, Ann Keohane C, et al. 2004. Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. Bioorg. Med. Chem. Lett. 14:3351-55
168. Liu CH, Thangada S, Lee MJ, Van Brocklyn JR, Spiegel S, Hla T. 1999. Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol. Biol. Cell 10:1179-90
169. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, et al. 2004. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Crit. Care Med. 169:1245-51
170. Mandala SM. 2001. Sphingosine-1-phosphate phosphatases. Prostaglandins Other Lipid Mediat. 64:143-56
171. Yatomi Y, Ozaki Y, Ohmori T, Igarashi Y. 2001. Sphingosine 1-phosphate: synthesis and release. Prostaglandins Other Lipid Mediat. 64:107-22
172. Pyne S, Pyne NJ. 2000. Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J. 349:385-402
173. Murata N, Sato K, Kon J, Tomura H, Yanagita M, et al. 2000. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352(Pt. 3):809-15
174. Yang L, Yatomi Y, Miura Y, Satoh K, Ozaki Y. 1999. Metabolism and functional effects of sphingolipids in blood cells. Br. J. Haematol. 107:282-93
175. Hisano N, Yatomi Y, Satoh K, Akimoto S, Mitsumata M, et al. 1999.
176. Graeler M, Shankar G, Goetzl EJ. 2002. Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate. J. Immunol. 169:4084-87
177. Dorsam G, Graeler MH, Seroogy C, Kong Y, Voice JK, Goetzl EJ. 2003. Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. J. Immunol. 171:3500-7
178. Chu P, Pardo J, Zhao H, Li CC, Pali E, et al. 2003. Systematic identification of regulatory proteins critical for T-cell activation. J. Biol. 2:21.1-21.16. doi: 10.1186/1475-4924-2-21
179. Zhang WB, Navenot JM, Haribabu B, Tamamura H, Hiramatu K, et al. 2002. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. J. Biol. Chem. 277:24515-21
180. Nakayama T, Kasprowicz DJ. Yamashita M, Schubert LA, Gillard G, et al. 2002. The generation of mature, single-positive thymocytes in vivo is dysregulated by CD69 blockade or overexpression. J. Immunol. 168:87-94
181. Feng C, Woodside KJ, Vance BA, El-Khoury D, Canelles M, et al. 2002. A potential role for CD69 in thymocyte emigration. Int. Immunol. 14:535-44
182. Lauzurica P, Sancho D, Torres M, Albella B, Marazuela M, et al. 2000. Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. Blood 95:2312-20
183. Sprent J, Miller JFAP, Mitchell GF. 1971. Antigen-induced selective recruitment of circulating lymphocytes. Cell. Immunol. 2:171-81
184. Rowley DA, Gowans JL, Atkins RC, Ford WL, Smith ME. 1972. The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats. J. Exp. Med. 136:499-513
185. Graeler M, Goetzl EJ. 2002. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J. 16:1874-78
186. Hall JG, Morris B. 1965. The immediate effect of antigens on the cell output of a lymph node. Br. J. Exp. Pathol. 46:450-54
187. Mann EA, Markovic SN, Murasko DM. 1989. Inhibition of lymphocyte recirculation by murine interferon: effects of various interferon preparations and timing of administration. J. Interferon Res. 9:35-51
188. Young AJ, Seabrook TJ, Marston WL, Dudler L, Hay JB. 2000. A role for lymphatic endothelium in the sequestration of recirculating γδ T cells in TNF-α-stimulated lymph nodes. Eur. J. Immunol. 30:327-34
189. Martín-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, et al. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198:615-21
190. McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, et al. 2003. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 4:1199-205
191. Rollins BJ. 1997. Chemokines. Blood 90:909-28
192. Youn B-S, Kwon BS. 2000. MIP-1g/MRP-2. In Cytokine Reference, ed. JJ Oppenheim, M Feldman, pp. 1237-43. New York: Academic
193. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, et al. 2003. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197:1537-49
194. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, et al. 1995. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28:495-500
195. Gleichmann M, Gillen C, Czardybon M, Bosse F, Greiner-Petter R, et al. 2000. Cloning and characterization of SDF-1γ, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur. J. Neurosci. 12:1857-66
196. Vassileva G, Soto H, Zlotnik A, Nakano H, Kakiuchi T, et al. 1999. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J. Exp. Med. 190:1183-88
197. Nakano H, Gunn MD. 2001. Gene duplications at the chemokine locus on mouse chromosome 4: multiple strain-specific haplotypes and the deletion of secondary lymphoid-organ chemokine and EBI-1 ligand chemokine genes in the plt mutation. J. Immunol. 166:361-69